Advanced PET Imaging, Nuclear Medicine, and Therapy: From Diagnostics to Theranostics
October 16 - 17, 2025 - NV USCME Science
info@cmescience.com
Phone:6504404424
This course provides a clinical perspective of PET/CT imaging and the emerging use of Theranostic agents within Nuclear Medicine. A broad perspective on the economic, clinical, and academic aspects of the latest trends in PET/CT imaging and Nuclear Medicine therapy will be presented. At the conclusion of this course, participants will be able to: . Describe new developments in the merger of diagnostic and therapeutic radioligands for PET/CT imaging and therapy with specific focus on DOTA, PSMA, and PRRT . Describe the logistics of bringing these new diagnostic and therapeutic technologies to clinical practice . Identify the key clinical indications for new emerging tracers for Neuroendocrine Tumor and Prostate cancer using somatostatin receptor and PSMA PET/CT imaging . Review and discuss the standard-of-care clinical application and advanced interpretation of FDG PET/CT URLs: Website: https://go.evvnt.com/2357369-0?pid=10337 Tickets: https://go.evvnt.com/2357369-2?pid=10337 Virtual: https://go.evvnt.com/2357369-3?pid=10337 Prices: Practicing Physician/Industry: USD 1495.00, Military/Retired/Scientist/VA: USD 1295.00, PA/Nurse: USD 1195.00, Resident/Fellow: USD 1095.00, Technologist: USD 995.00 Speakers: Phillip Kuo, MD, PhD, FACR, Andrew Quon, MD, Don C. Yoo, MD Category: Conferences | Science, Health and Medicine | CME (Continuing Medical Education) Date and Time: 16th October 2025 at 7:30 am to 17th October 2025 at 4:45 pm Venue details: Encore At Wynn Las Vegas, 3121 S Las Vegas Blvd, Las Vegas, NV, 89109, United States